Lb Pharmaceuticals (LBRX) Capital Expenditures (2024 - 2026)
Lb Pharmaceuticals' quarterly Capital Expenditures came in at $32000.0 in Q1 2026, up 52.38% year-on-year from $21000.0 in Q1 2025, and down 20.0% quarter-over-quarter from $40000.0 in Q4 2025.
Lb Pharmaceuticals has reported Capital Expenditures for 3 years, with the latest figure at $32000.0 in Q1 2026.
- For the quarter ending Q1 2026, Capital Expenditures rose 52.38% year-over-year to $32000.0; the trailing twelve-month figure through Mar 2026 stood at $331000.0 (changed N/A YoY), and the FY2025 full-year result was $52000.0, down 93.24% from the prior year.
- Capital Expenditures for Q1 2026 stood at $32000.0, down from $40000.0 in the prior quarter.
- The five-year high for Capital Expenditures was $238000.0 in Q4 2024, with the low at $21000.0 in Q1 2025.
- Average Capital Expenditures over 3 years is $82750.0, with a median of $36000.0 recorded in 2025.
- Year-over-year, Capital Expenditures plunged 83.19% in 2025 and soared 52.38% in 2026.
- Tracing LBRX's Capital Expenditures over 3 years: stood at $238000.0 in 2024, then slumped by 83.19% to $40000.0 in 2025, then declined by 20.0% to $32000.0 in 2026.
- The last three Capital Expenditures figures came in at $32000.0 (Q1 2026), $40000.0 (Q4 2025), and $21000.0 (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 133.40 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 230.60 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 21.83 Mn |
| 10 | Lb Pharmaceuticals | 789.92 Mn | 789.92 Mn | - | 32,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32,000.00 |
| Mar 31, 2026 | 32,000.00 |
| Dec 31, 2025 | 40,000.00 |
| Dec 31, 2025 | 40,000.00 |
| Mar 31, 2025 | 21,000.00 |
| Mar 31, 2025 | 21,000.00 |
| Dec 31, 2024 | 238,000.00 |
| Dec 31, 2024 | 238,000.00 |